BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16887348)

  • 1. Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists.
    Ma V; Bannon AW; Baumgartner J; Hale C; Hsieh F; Hulme C; Rorrer K; Salon J; van Staden C; Tempest P
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5066-72. PubMed ID: 16887348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
    Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
    J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and SAR of 4-amino-2-biarylbutylurea MCH 1 receptor antagonists through solid-phase parallel synthesis.
    Guo T; Hunter RC; Gu H; Rokosz LL; Stauffer TM; Hobbs DW
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3691-5. PubMed ID: 15953726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).
    Rowbottom MW; Vickers TD; Tamiya J; Zhang M; Dyck B; Grey J; Schwarz D; Heise CE; Hedrick M; Wen J; Tang H; Wang H; Fisher A; Aparicio A; Saunders J; Goodfellow VS
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2171-8. PubMed ID: 17350839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A virtual screening approach to finding novel and potent antagonists at the melanin-concentrating hormone 1 receptor.
    Clark DE; Higgs C; Wren SP; Dyke HJ; Wong M; Norman D; Lockey PM; Roach AG
    J Med Chem; 2004 Jul; 47(16):3962-71. PubMed ID: 15267235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of a novel series of melanin-concentrating hormone (MCH) receptor antagonists.
    Arienzo R; Clark DE; Cramp S; Daly S; Dyke HJ; Lockey P; Norman D; Roach AG; Stuttle K; Tomlinson M; Wong M; Wren SP
    Bioorg Med Chem Lett; 2004 Aug; 14(15):4099-102. PubMed ID: 15225734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of melanin-concentrating hormone receptor R1 antagonists using high-throughput synthesis.
    Su J; McKittrick BA; Tang H; Czarniecki M; Greenlee WJ; Hawes BE; O'Neill K
    Bioorg Med Chem; 2005 Mar; 13(5):1829-36. PubMed ID: 15698800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel bicyclo[4.1.0]heptane and bicyclo[3.1.0]hexane derivatives as melanin-concentrating hormone receptor R1 antagonists.
    Su J; Tang H; McKittrick BA; Gu H; Guo T; Qian G; Burnett DA; Clader JW; Greenlee WJ; Hawes BE; O'neill K; Spar B; Weig B; Kowalski T; Sorota S
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4845-50. PubMed ID: 17604169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel diarylketoxime derivatives as selective and orally active melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Kameda M; Ando M; Miyazoe H; Sekino E; Ito S; Masutani K; Kamijo K; Takezawa A; Moriya M; Ito M; Ito J; Nakase K; Matsushita H; Ishihara A; Takenaga N; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5339-45. PubMed ID: 19683441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists.
    Balavoine F; Malabre P; Alleaume T; Rey A; Cherfils V; Jeanneton O; Seigneurin-Venin S; Revah F
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3754-9. PubMed ID: 17448659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1.
    Kanuma K; Omodera K; Nishiguchi M; Funakoshi T; Chaki S; Semple G; Tran TA; Kramer B; Hsu D; Casper M; Thomsen B; Sekiguchi Y
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3853-6. PubMed ID: 16002290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
    McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
    J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice.
    Ito M; Ishihara A; Gomori A; Egashira S; Matsushita H; Mashiko S; Ito J; Ito M; Nakase K; Haga Y; Iwaasa H; Suzuki T; Ohtake N; Moriya M; Sato N; MacNeil DJ; Takenaga N; Tokita S; Kanatani A
    Eur J Pharmacol; 2009 Dec; 624(1-3):77-83. PubMed ID: 19836369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists.
    Wu WL; Burnett DA; Spring R; Qiang L; Sasikumar TK; Domalski MS; Greenlee WJ; O'Neill K; Hawes BE
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3668-73. PubMed ID: 16690312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery and optimization of pyrimidinone-containing MCH R1 antagonists.
    Hertzog DL; Al-Barazanji KA; Bigham EC; Bishop MJ; Britt CS; Carlton DL; Cooper JP; Daniels AJ; Garrido DM; Goetz AS; Grizzle MK; Guo YC; Handlon AL; Ignar DM; Morgan RO; Peat AJ; Tavares FX; Zhou H
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4723-7. PubMed ID: 16870432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 1.
    Rowbottom MW; Vickers TD; Dyck B; Grey J; Tamiya J; Zhang M; Kiankarimi M; Wu D; Dwight W; Wade WS; Schwarz D; Heise CE; Madan A; Fisher A; Petroski R; Goodfellow VS
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4450-7. PubMed ID: 16814542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of melanin-concentrating hormone receptor and its impact on drug discovery.
    Saito Y; Maruyama K
    J Exp Zool A Comp Exp Biol; 2006 Sep; 305(9):761-8. PubMed ID: 16902961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for obesity treatment: MCH receptor antagonists.
    Collins CA; Kym PR
    Curr Opin Investig Drugs; 2003 Apr; 4(4):386-94. PubMed ID: 12808876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.